196 related articles for article (PubMed ID: 8415704)
1. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1.
Doucas V; Brockes JP; Yaniv M; de Thé H; Dejean A
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9345-9. PubMed ID: 8415704
[TBL] [Abstract][Full Text] [Related]
2. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
[TBL] [Abstract][Full Text] [Related]
3. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Dejean A
Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
[TBL] [Abstract][Full Text] [Related]
4. Opposite effects of the acute promyelocytic leukemia PML-retinoic acid receptor alpha (RAR alpha) and PLZF-RAR alpha fusion proteins on retinoic acid signalling.
Ruthardt M; Testa U; Nervi C; Ferrucci PF; Grignani F; Puccetti E; Grignani F; Peschle C; Pelicci PG
Mol Cell Biol; 1997 Aug; 17(8):4859-69. PubMed ID: 9234742
[TBL] [Abstract][Full Text] [Related]
5. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
6. PML protein expression in hematopoietic and acute promyelocytic leukemia cells.
Daniel MT; Koken M; Romagné O; Barbey S; Bazarbachi A; Stadler M; Guillemin MC; Degos L; Chomienne C; de Thé H
Blood; 1993 Sep; 82(6):1858-67. PubMed ID: 8400236
[TBL] [Abstract][Full Text] [Related]
7. The molecular genetics of acute promyelocytic leukemia.
Grignani F; Fagioli M; Ferrucci PF; Alcalay M; Pelicci PG
Blood Rev; 1993 Jun; 7(2):87-93. PubMed ID: 8396481
[TBL] [Abstract][Full Text] [Related]
8. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML.
Kakizuka A; Miller WH; Umesono K; Warrell RP; Frankel SR; Murty VV; Dmitrovsky E; Evans RM
Cell; 1991 Aug; 66(4):663-74. PubMed ID: 1652368
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.
Benedetti L; Levin AA; Scicchitano BM; Grignani F; Allenby G; Diverio D; Lo Coco F; Avvisati G; Ruthardt M; Adamo S; Pelicci PG; Nervi C
Blood; 1997 Aug; 90(3):1175-85. PubMed ID: 9242550
[TBL] [Abstract][Full Text] [Related]
10. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Jansen J; Dejean A
Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
[TBL] [Abstract][Full Text] [Related]
11. The molecular biology of acute promyelocytic leukemia.
Slack JL; Gallagher RE
Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864
[TBL] [Abstract][Full Text] [Related]
12. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
[TBL] [Abstract][Full Text] [Related]
13. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
[TBL] [Abstract][Full Text] [Related]
14. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
[TBL] [Abstract][Full Text] [Related]
15. PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu ZM; Chin KV; Liu JH; Lozano G; Chang KS
Mol Cell Biol; 1994 Oct; 14(10):6858-67. PubMed ID: 7935403
[TBL] [Abstract][Full Text] [Related]
16. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
17. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
[TBL] [Abstract][Full Text] [Related]
18. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.
de Thé H; Lavau C; Marchio A; Chomienne C; Degos L; Dejean A
Cell; 1991 Aug; 66(4):675-84. PubMed ID: 1652369
[TBL] [Abstract][Full Text] [Related]
19. Genomic variability and alternative splicing generate multiple PML/RAR alpha transcripts that encode aberrant PML proteins and PML/RAR alpha isoforms in acute promyelocytic leukaemia.
Pandolfi PP; Alcalay M; Fagioli M; Zangrilli D; Mencarelli A; Diverio D; Biondi A; Lo Coco F; Rambaldi A; Grignani F
EMBO J; 1992 Apr; 11(4):1397-407. PubMed ID: 1314166
[TBL] [Abstract][Full Text] [Related]
20. Multimeric complexes of the PML-retinoic acid receptor alpha fusion protein in acute promyelocytic leukemia cells and interference with retinoid and peroxisome-proliferator signaling pathways.
Jansen JH; Mahfoudi A; Rambaud S; Lavau C; Wahli W; Dejean A
Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7401-5. PubMed ID: 7638205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
